Objectives:
Catechol-O-methyltransferase (COMT), a key enzyme in degrading stress hormones, may influence susceptibility to delirium. Individuals with the COMT (rs4680) Val/Val genotype (designated “warriors”) withstand the onset of neuropsychiatric disorders and cognitive decline, while individuals with Met/Met and Val/Met genotypes (“non-warriors”) are more susceptible to these conditions. We evaluated whether COMT genotype modifies the established association between acute phase reactant (stress marker) C-reactive protein (CRP) and postoperative delirium.
Design:
Prospective cohort.
Setting:
Two academic medical centers.
Participants:
547 patients age ≥70 undergoing major non-cardiac surgery.
Measurements:
We collected blood, extracted DNA, and performed COMT genotyping using allele specific PCR assays, considering warriors vs. non-warriors. High plasma CRP, measured on postoperative day 2 (POD2) using ELISA, was defined by the highest sample-based quartile (≥234.12 mg/L). Delirium was determined using the Confusion Assessment Method, augmented by a validated chart review. We used generalized linear models adjusted for age, sex, and surgery type, stratified by COMT genotype, to determine whether the association between CRP and delirium differs by COMT.
Results:
Prevalence of COMT warriors was 26%, and postoperative delirium occurred in 23%. Among COMT warriors, high CRP was not associated with delirium (relative risk[RR] 1.0, 95% confidence interval[CI] 0.4–2.6). In contrast, among non-warriors, we found the expected relationship of high CRP and delirium (RR 1.5, 95% CI 1.1–2.2).
Conclusions:
COMT warriors may be protected against the increased risk of delirium associated with high POD2 CRP. With further confirmation, COMT genotype may help to target interventions for delirium prevention to the vulnerable non-warrior group.